Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

DNAe nets bank facility for blood infection IVD
December 2015
EDIT CONNECT
  DNAe

SHARING OPTIONS:

LONDON & ALBUQUERQUE—DNAe recently announced that it has secured a bank facility of £25 million ($38 million) to fund the final development stages—including clinical trials and product launch—of DNAe Diagnostics’ point-of-need test for serious blood infections. The company is utilizing its Genalysis semiconductor DNA sequencing technology to develop a rapid in-vitro diagnostic for serious blood infections that lead to sepsis. The test combines DNA Electronics Inc.’s novel Pathogen Capture System technology with DNAe’s Genalysis platform for a complete blood-to-result solution that offers actionable results in two to three hours. Prof. Chris Toumazou, executive chairman of DNAe, said the test’s development is going well, adding that “Our semiconductor DNA semiconductor technology has the potential to revolutionize how patients with these life-threatening infections are treated, and the bank facility demonstrates the confidence of the bank and of our shareholders in DNAe’s technology, team and strategy to achieve this.”
 
Code:

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.